MD Anderson Events
Keynote-Dr. Andrew Futreal "The Somatic Genetic Architecture of Human Cancer"
The University of Texas at Houston's Graduate School of Biomedical Science Human and Molecular Genetics program is proud to host as one of their keynote speakers, Dr. Andrew Futreal, PhD from M.D. Anderson Cancer Center / honorary faculty at the Wellcome Sanger Institute, as part of the 17th annual Human and Molecular Genetics Symposium. We ask that you please join us for this exciting event!
Date: 4/11/14, 3pm to 4pm
Time: 4/11/14, 3pm to 4pm
Location: Griffin Conference and Education Center, South Campus Research Building 2, Floor 1, Conference Rooms 1-6
Directions: Seminar is being held in South Campus Research Building 2 conference rooms 1-2 (2SCR1.4015 & 2SCR1.4019). This location is easily accessed by the Blue and Black shuttle to the SCRB1/2 stop.
Speaker Bio: Before joining MD Anderson in July 2012, he was the co-director of the Cancer Genome Project at the Wellcome Trust Sanger Institute, where he continues to be an honorary faculty member. His chief scientific accomplishments include the identification of the BRCA1 and BRCA2 breast/ovarian cancer susceptibility genes, leading a pioneering effort in large-scale systematic cancer genomics leading to the identification the BRAF mutations in melanoma, ERBB2 mutations in non-small cell lung cancer and multiple new cancer genes in renal cell carcinoma. He has published over 182 papers in peer-reviewed journals. He received the NIH Public Service Award in 1995 for discovering the BRCA1 gene involved in subsets of breast and ovarian cancer. Here at MD Anderson he is a platform leader for genomics and informatics for the Moonshot initiative and plans on applying his knowledge of cancer genomics to improve both short-term and long-term patient outcomes extending to cancer survivorship.
Contact: Jacquelyn Reuther - (713) 834-6356 - firstname.lastname@example.org
flyer_Futreal14.pdf (PDF, 146 KB)
- How to Achieve Excellence in Science
- Repair of Radiation-Induced Double-Strand Breaks in the Genome via Alternative End-Joining: A Potential Therapeutic Target for Enhancing Tumor Radiosensitivity
- Pancreas Cancer Seminar Series
- Symposium on Molecular Imaging with Mass Spectrometry Techniques
- Training in Brain Tumor Research Seminars presents John de Groot, M.D.
- Experimental therapeutics using preclinical mouse models of early or late stage metastatic disease
- Value-Based Head and Neck Cancer Care
- Fourth International Conference on Cancer and the Heart
- Current Concepts in Head and Neck Surgery
- Training in Brain Tumor Research Seminars presents Mohammad Belayat Hossain, Ph.D.